MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Alterations of Plasma Membrane in Parkinson’s disease LRRK2 I1371V iPSC derived Astrocytes contribute to the vulnerability of the niche cells to Extracellular α-Synuclein

    I. Datta, R. Banerjee, V. Holla, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

  • Altered Tryptophan Metabolism and the Role of the Kynurenine Pathway in Multiple System Atrophy

    R. Nagao, K. Kawabata, Y. Mizutani, H. Watanabe (Toyoake, Japan)

  • Ameliorating effect of linalool on anxiety disorders in Parkinson’s mice and related mechanisms

    F. Lou, M. Li (Shenyang, China)

  • Amitriptyline-Induced Rabbit Syndrome: A Case of Refractory Oral Vertical Dyskinesia

    A. Medhus, E. Krause (Austin, USA)

  • Amplification Parameters of the Alpha-Synuclein Seed Amplification Assay on CSF Predict the Clinical Subtype of Parkinson’s Disease at 10-Year Follow-Up

    P. Grillo, GM. Riboldi, A. Pisani, UJ. Kang, SM. Fereshtehnejad (Pavia, Italy)

  • Amygdala-predominant Lewy Body Disease is a Lens for Understanding Pathogenesis and the Alpha-synuclein Seeding Assay in Human Postmortem Brain

    D. Fischer, L. Vandevrede, W. Seeley, S. Spina, S. Li, W. Lee, T. Lamore, F. Wekselman, A. Lario Lago, L. Grinberg (San Francisco, USA)

  • An Atypical Case of Ataxia and Hyperkinetic Movements

    S. Gunawardena, U. Shuaib (Cleveland, USA)

  • An Exercise Prescription to Slow the Progression of Parkinson’s Disease

    J. Alberts, A. Rosenfeldt, C. Lopez-Lennon, E. Jansen, C. Felix, E. Zimmerman, P. Imrey, H. Fernandez, K. Mckee, L. Dibble (Cleveland, USA)

  • An Interesting Case of Oculo-Palatal-Pharyngeal Tremor

    R. Robinson, A. Oswal, MT. Hu (Oxford, United Kingdom)

  • Anal Sphincter EMG changes can Progress over Time and can be considered as a Prognostic Marker in MSA

    L. Lei, J. Bermejillo, P. Malladi, J. Panicker, A. Batla (London, United Kingdom)

  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #24970 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley